1. European Medicines Agency (EMA). Valproate and related substances: new measures to avoid valproate exposure in pregnancy endorsed. 2018. https://www.ema.europa.eu/en/medicines/human/referrals/valproate-related-substances-0. Accessed 23 Apr 2019.
2. Daw JR, Hanley GE, Greyson DL, Morgan SG. Prescription drug use during pregnancy in developed countries: a systematic review. Pharmacoepidemiol Drug Saf. 2011;20:895–902.
3. Blattner CM, Danesh M, Safaee M, Murase JE. Understanding the new FDA pregnancy and lactation labeling rules. Int J Womens Dermatol. 2016;2:5–7.
4. Australian Government, Department of Health. Therapeutic Goods Administration (TGA). Prescribing medicines in pregnancy database. 2019. https://www.tga.gov.au/prescribing-medicines-pregnancy-database. Accessed 3 Jan 2020.
5. Swedish Catalogue of Approved Drugs (FASS). https://www.fass.se/LIF/startpage. Accessed 3 Jan 2020.